[Re-evaluation of current antimicrobials. Series 21: cefixime. Discussion].
D000284:Administration, Oral; D001419:Bacteria / Q000187:drug effects; D020682:Cefixime; D002439:Cefotaxime / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000494:pharmacology; D004352:Drug Resistance, Microbial; D006801:Humans; D012141:Respiratory Tract Infections / Q000188:drug therapy / Q000382:microbiology
D020682:Cefixime; D002439:Cefotaxime